HEPSERA Side Effects

6956859-7 | Asthenia, Blood Alkaline Phosphatase Increased, Bone Pain, Bone Scan Abnormal, Hypophosphataemia, Nephropathy Toxic, Osteomalacia, Osteoporosis
on Mar 05, 2009 Male patient from KOREA, REPUBLIC OF , 42 years of age, was treated with Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood alkaline phosphatase increased, bone pain, bone scan abnormal, hypophosphataemia, nephropathy toxic, osteomalacia, osteoporosis (What is osteoporosis?). Hepsera dosage: . Patient was hospitalized.

6931984-5 | Osteomalacia, Vitamin D Deficiency
Patient was taking Hepsera (View Usage). Patient had the following side effects: osteomalacia, vitamin d deficiency on Jul 21, 2010 from GREECE Additional patient health information: Female patient , 57 years of age, . Hepsera dosage: .

6931982-1 | Osteomalacia, Vitamin D Deficiency
Adverse event was reported on Jul 21, 2010 by a Female patient taking Hepsera (View Usage) (Dosage: ) . Location: GREECE , 68 years of age, After Hepsera was administered, patient had the following side effects: osteomalacia, vitamin d deficiency.

6884083-5 | Osteomalacia, Vitamin D Deficiency
on Jul 21, 2010 Female patient from GREECE , 68 years of age, was treated with Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: osteomalacia, vitamin d deficiency. Hepsera dosage: .


6879625-X | Osteomalacia, Vitamin D Deficiency
on Jul 21, 2010 Female patient from GREECE , 57 years of age, was treated with Hepsera (View Usage). Patient had the following side effects: osteomalacia, vitamin d deficiency. Hepsera dosage: .

6872107-0 | Osteomalacia, Vitamin D Deficiency
Patient was taking Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: osteomalacia, vitamin d deficiency on Jul 14, 2010 from GREECE Additional patient health information: Female patient , 68 years of age, . Hepsera dosage: .

6866480-7 | Osteomalacia, Vitamin D Deficiency
Adverse event was reported on Jul 14, 2010 by a Female patient taking Hepsera (View Usage) (Dosage: ) . Location: GREECE , 57 years of age, Patient experienced the following unwanted or unexpected effects: osteomalacia, vitamin d deficiency.

6822869-3 | Hepatic Cirrhosis, Liver Function Test Abnormal, Malaise
on Jun 28, 2010 Male patient from JAPAN , 51 years of age, was diagnosed with hepatic cirrhosis and was treated with Hepsera (View Usage). Patient had the following side effects: hepatic cirrhosis, liver function test abnormal, malaise. Hepsera dosage: . During the same period patient was treated with ZEFIX (View Zefix Review and Zefix Label ).

6766897-5 | Acidosis Hyperchloraemic, Blood 25-hydroxycholecalciferol Decreased, Bone Pain, Fanconi Syndrome Acquired, Hypocalcaemia, Hypokalaemia, Hypophosphataemia, Hypouricaemia, Osteomalacia
on Jun 02, 2010 Male patient from JAPAN , 72 years of age, was diagnosed with hepatitis b (What is hepatitis b?), gastritis and was treated with Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: acidosis hyperchloraemic, blood 25-hydroxycholecalciferol decreased, bone pain, fanconi syndrome acquired, hypocalcaemia, hypokalaemia, hypophosphataemia, hypouricaemia, osteomalacia. Hepsera dosage: . During the same period patient was treated with ZEFIX (View Zefix Review and Zefix Label ), GASTER D (View Gaster D Review and Gaster D Label ). Patient was hospitalized.

6763221-9 | Headache, Thyroid Cancer
Patient was taking Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), thyroid cancer (What is thyroid cancer?) on Jun 01, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 45 years of age, . Hepsera dosage: . During the same period patient was treated with ZEFFIX (View Zeffix Review and Zeffix Label ).

6728301-2 | Abortion Spontaneous
Adverse event was reported on May 11, 2010 by a Female patient taking Hepsera (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: GERMANY , 41 years of age, Patient had the following side effects: abortion spontaneous.

6722714-0 | Fanconi Syndrome Acquired, Renal Failure
on May 05, 2010 Male patient from FRANCE , weighting 154.3 lb, was diagnosed with hepatitis b (What is hepatitis b?), hepatitis c (What is hepatitis c?), depression (What is depression?), arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), benign prostatic hyperplasia, hypertension, cardiac failure and was treated with Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: fanconi syndrome acquired, renal failure. Hepsera dosage: . During the same period patient was treated with ANAFRANIL (View Anafranil Review and Anafranil Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), OMEXEL (View Omexel Review and Omexel Label ), TARKA (View Tarka Review and Tarka Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6695311-3 | Acidosis Hyperchloraemic, Blood 25-hydroxycholecalciferol Decreased, Bone Pain, Fanconi Syndrome Acquired, Hypocalcaemia, Hypokalaemia, Hypophosphataemia, Hypouricaemia, Osteomalacia
on Apr 09, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with hepatitis b (What is hepatitis b?), gastritis and was treated with Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis hyperchloraemic, blood 25-hydroxycholecalciferol decreased, bone pain, fanconi syndrome acquired, hypocalcaemia, hypokalaemia, hypophosphataemia, hypouricaemia, osteomalacia. Hepsera dosage: . During the same period patient was treated with ZEFIX (View Zefix Review and Zefix Label ), GASTER D (View Gaster D Review and Gaster D Label ). Patient was hospitalized.

6683444-7 | Acidosis Hyperchloraemic, Blood 25-hydroxycholecalciferol Decreased, Bone Pain, Fanconi Syndrome Acquired, Hypocalcaemia, Hypokalaemia, Hypophosphataemia, Hypouricaemia, Osteomalacia
Patient was taking Hepsera (View Usage). Patient had the following side effects: acidosis hyperchloraemic, blood 25-hydroxycholecalciferol decreased, bone pain, fanconi syndrome acquired, hypocalcaemia, hypokalaemia, hypophosphataemia, hypouricaemia, osteomalacia on Apr 06, 2010 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Hepsera dosage: . Patient was hospitalized.

6656771-7 | Amnesia, Fanconi Syndrome Acquired, Hypokalaemia, Hypophosphataemia, Myalgia, Osteoporosis
Adverse event was reported on Mar 22, 2010 by a Male patient taking Hepsera (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?), hiv infection (What is hiv infection?) and. Location: UNITED STATES , 49 years of age, weighting 132.1 lb, After Hepsera was administered, patient had the following side effects: amnesia, fanconi syndrome acquired, hypokalaemia, hypophosphataemia, myalgia, osteoporosis (What is osteoporosis?). During the same period patient was treated with VIREAD (View Viread Review and Viread Label ). Patient was hospitalized and became disabled.

6618699-8 | Hepatic Enzyme Increased
on Feb 25, 2010 Male patient from KOREA, REPUBLIC OF , weighting 163.1 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased. Hepsera dosage: 10mg Per Day. During the same period patient was treated with ADELAVIN (View Adelavin Review and Adelavin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ). Patient was hospitalized.

6608237-8 | Fanconi Syndrome Acquired, Osteomalacia
on Feb 25, 2010 Female patient from JAPAN , 57 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Hepsera (View Usage). Patient had the following side effects: fanconi syndrome acquired, osteomalacia. Hepsera dosage: 10mg Per Day. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6606668-3 | Fanconi Syndrome Acquired, Osteomalacia
Patient was taking Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: fanconi syndrome acquired, osteomalacia on Feb 25, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Hepsera dosage: 10mg Per Day. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6606662-2 | Fanconi Syndrome Acquired, Osteomalacia
Adverse event was reported on Feb 15, 2010 by a Female patient taking Hepsera (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?), gastritis, hepatic cirrhosis, osteoporosis (What is osteoporosis?) and. Location: UNITED KINGDOM , 57 years of age, weighting 321.9 lb, Patient experienced the following unwanted or unexpected effects: fanconi syndrome acquired, osteomalacia. During the same period patient was treated with ZEFIX (View Zefix Review and Zefix Label ), GASTER (View Gaster Review and Gaster Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), PORTALAK (View Portalak Review and Portalak Label ), LIVACT (View Livact Review and Livact Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), ALFAROL (View Alfarol Review and Alfarol Label ). Patient was hospitalized.

6606655-5 | Ascites
on Feb 17, 2010 Female patient from KOREA, REPUBLIC OF , weighting 130.1 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Hepsera (View Usage). Patient had the following side effects: ascites. Hepsera dosage: 10mg Per Day. During the same period patient was treated with FOLIUM (View Folium Review and Folium Label ), LIVACT (View Livact Review and Livact Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), ZEFFIX (View Zeffix Review and Zeffix Label ), LASIX (View Lasix Review and Lasix Label ), COUGH SYRUP (View Cough Syrup Review and Cough Syrup Label ), ROXAN (View Roxan Review and Roxan Label ), ULCERMIN (View Ulcermin Review and Ulcermin Label ). Patient was hospitalized.

6600488-1 | Hepatic Neoplasm Malignant, Lymphoma
on Feb 23, 2010 Female patient from UNITED STATES , 59 years of age, weighting 120.0 lb, was treated with Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: hepatic neoplasm malignant, lymphoma (What is lymphoma?). Hepsera dosage: .

6597059-2 | Alanine Aminotransferase Increased, Hepatitis B Dna Increased, Therapeutic Response Decreased
Patient was taking Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, hepatitis b dna increased, therapeutic response decreased on Feb 23, 2010 from JAPAN Additional patient health information: Male patient , 52 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Hepsera dosage: 10mg Per Day. During the same period patient was treated with LAMIVUDINE (100mg Per Day) (View Lamivudine Review and Lamivudine Label ), ENTECAVIR (View Entecavir Review and Entecavir Label ), INSULIN (View Insulin Review and Insulin Label ).

6597059-2 | Alanine Aminotransferase Increased, Hepatitis B Dna Increased, Therapeutic Response Decreased
Adverse event was reported on Feb 23, 2010 by a Male patient taking Hepsera (View Usage) (Dosage: 10mg Per Day) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: JAPAN , 52 years of age, Patient had the following side effects: alanine aminotransferase increased, hepatitis b dna increased, therapeutic response decreased. During the same period patient was treated with LAMIVUDINE (100mg Per Day) (View Lamivudine Review and Lamivudine Label ), ENTECAVIR (View Entecavir Review and Entecavir Label ), INSULIN (View Insulin Review and Insulin Label ).

6597058-0 | Aminoaciduria, Arthralgia, Back Pain, Blood Alkaline Phosphatase Increased, Bone Disorder, Fanconi Syndrome, Glycosuria, Hepatitis B Dna Increased, Hypophosphataemia
on Feb 15, 2010 Female patient from JAPAN , weighting 66.14 lb, was diagnosed with hepatitis b (What is hepatitis b?), gastritis, hepatic cirrhosis, osteoporosis (What is osteoporosis?) and was treated with Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: aminoaciduria, arthralgia, back pain (What is back pain?), blood alkaline phosphatase increased, bone disorder, fanconi syndrome, glycosuria, hepatitis b dna increased, hypophosphataemia. Hepsera dosage: 100mg Per Day. During the same period patient was treated with ZEFIX (View Zefix Review and Zefix Label ), GASTER (20mg Per Day) (View Gaster Review and Gaster Label ), MUCOSTA (300mg Per Day) (View Mucosta Review and Mucosta Label ), PORTALAK (18g Per Day) (View Portalak Review and Portalak Label ), LIVACT (12.45g Per Day) (View Livact Review and Livact Label ), URSO 250 (300mg Per Day) (View Urso 250 Review and Urso 250 Label ), ALFAROL (1mcg Per Day) (View Alfarol Review and Alfarol Label ), BENET (2.5mg Per Day) (View Benet Review and Benet Label ). Patient was hospitalized.

6589572-9 | Hepatic Neoplasm Malignant Recurrent
on Feb 08, 2010 Male patient from KOREA, REPUBLIC OF , weighting 122.8 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant recurrent. Hepsera dosage: 10mg Per Day. During the same period patient was treated with URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), ISOLEUCINE (View Isoleucine Review and Isoleucine Label ), VALINE (View Valine Review and Valine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), GODEX (View Godex Review and Godex Label ), HARNAL D (View Harnal D Review and Harnal D Label ). Patient was hospitalized.

6589571-7 | Hepatic Neoplasm Malignant Recurrent
Patient was taking Hepsera (View Usage). Patient had the following side effects: hepatic neoplasm malignant recurrent on Feb 08, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , weighting 132.1 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Hepsera dosage: 10mg Per Day. Patient was hospitalized.

6589537-7 | Abortion Spontaneous
Adverse event was reported on Feb 12, 2010 by a Female patient taking Hepsera (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: UNITED STATES , 43 years of age, After Hepsera was administered, patient had the following side effects: abortion spontaneous.

6585534-6 | Fanconi Syndrome Acquired, Renal Failure
on Feb 09, 2010 Male patient from FRANCE , weighting 154.3 lb, was diagnosed with hepatitis b (What is hepatitis b?), hepatitis c (What is hepatitis c?), depression (What is depression?), arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), benign prostatic hyperplasia, hypertension, cardiac failure and was treated with Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: fanconi syndrome acquired, renal failure. Hepsera dosage: . During the same period patient was treated with ANAFRANIL (View Anafranil Review and Anafranil Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), OMEXEL (View Omexel Review and Omexel Label ), TARKA (View Tarka Review and Tarka Label ), LASILIX (View Lasilix Review and Lasilix Label ). Patient was hospitalized.

6577319-1 | Fanconi Syndrome Acquired, Renal Failure
on Feb 05, 2010 Male patient from FRANCE , weighting 154.3 lb, was diagnosed with hepatitis b (What is hepatitis b?), depression (What is depression?), arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), benign prostatic hyperplasia, hypertension, cardiac failure, anxiety (What is anxiety?) and was treated with Hepsera (View Usage). Patient had the following side effects: fanconi syndrome acquired, renal failure. Hepsera dosage: . During the same period patient was treated with ANAFRANIL (View Anafranil Review and Anafranil Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), OMEXEL (View Omexel Review and Omexel Label ), TARKA (View Tarka Review and Tarka Label ), LASILIX (View Lasilix Review and Lasilix Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6574386-6 | Ascites
Patient was taking Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: ascites on Jan 28, 2010 from KOREA, REPUBLIC OF Additional patient health information: Female patient , weighting 130.1 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Hepsera dosage: 10mg Per Day. During the same period patient was treated with FOLIUM (View Folium Review and Folium Label ), LIVACT (View Livact Review and Livact Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), ZEFFIX (View Zeffix Review and Zeffix Label ), LASIX (View Lasix Review and Lasix Label ), COUGH SYRUP (View Cough Syrup Review and Cough Syrup Label ), ROXAN (View Roxan Review and Roxan Label ), ULCERMIN (View Ulcermin Review and Ulcermin Label ). Patient was hospitalized.

6572844-1 | Hepatic Enzyme Increased
Adverse event was reported on Jan 27, 2010 by a Male patient taking Hepsera (View Usage) (Dosage: 10mg Per Day) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: KOREA, REPUBLIC OF , weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased. During the same period patient was treated with ADELAVIN (View Adelavin Review and Adelavin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ). Patient was hospitalized.

6572842-8 | Hepatic Neoplasm Malignant Recurrent
on Jan 27, 2010 Male patient from KOREA, REPUBLIC OF , weighting 132.1 lb, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Hepsera (View Usage). Patient had the following side effects: hepatic neoplasm malignant recurrent. Hepsera dosage: 10mg Per Day. Patient was hospitalized.

6572839-8 | Hepatic Neoplasm Malignant Recurrent
on Jan 27, 2010 Male patient from KOREA, REPUBLIC OF , weighting 122.8 lb, was treated with Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: hepatic neoplasm malignant recurrent. Hepsera dosage: 10mg Per Day. During the same period patient was treated with URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), ISOLEUCINE (View Isoleucine Review and Isoleucine Label ), VALINE (View Valine Review and Valine Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), GODEX (View Godex Review and Godex Label ), HARNAL D (View Harnal D Review and Harnal D Label ). Patient was hospitalized.

6557030-3 | Metastases To Abdominal Cavity
Patient was taking Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: metastases to abdominal cavity on Jan 19, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , weighting 129.0 lb, was diagnosed with hepatitis b (What is hepatitis b?), antiviral treatment, hypertension, gastric ulcer, vitamin c, hypovitaminosis and. Hepsera dosage: 10mg Per Day. During the same period patient was treated with ZEFFIX (View Zeffix Review and Zeffix Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ). Patient was hospitalized.

6552803-5 | Haematemesis
Adverse event was reported on Jan 14, 2010 by a Female patient taking Hepsera (View Usage) (Dosage: 10mg Per Day) was diagnosed with hepatitis b (What is hepatitis b?), antiviral treatment, vitamin c, varices oesophageal and. Location: KOREA, REPUBLIC OF , 61 years of age, weighting 144.6 lb, Patient had the following side effects: haematemesis. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ). Patient was hospitalized.

6551136-0 | Hepatic Neoplasm Malignant Recurrent
on Jan 14, 2010 Male patient from KOREA, REPUBLIC OF , 48 years of age, weighting 145.3 lb, was diagnosed with hepatitis b (What is hepatitis b?), prophylaxis and was treated with Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: hepatic neoplasm malignant recurrent. Hepsera dosage: 10mg Per Day. During the same period patient was treated with VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), ACSORBIC ACID (View Acsorbic Acid Review and Acsorbic Acid Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), MEPERIDINE HCL (View Meperidine Hcl Review and Meperidine Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6551070-6 | Jaundice
on Jan 14, 2010 Male patient from KOREA, REPUBLIC OF , weighting 138.9 lb, was diagnosed with hepatitis b (What is hepatitis b?), antiviral treatment and was treated with Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?). Hepsera dosage: 10mg Per Day. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), GRANISETRON (View Granisetron Review and Granisetron Label ). Patient was hospitalized.

6551048-2 | Abdominal Pain, Hepatic Encephalopathy, Muscle Spasms, Paraesthesia
Patient was taking Hepsera (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), hepatic encephalopathy, muscle spasms, paraesthesia on Jan 13, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 48 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Hepsera dosage: 10mg Per Day. During the same period patient was treated with VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6551037-8 | Tubulointerstitial Nephritis
Adverse event was reported on Jan 12, 2010 by a Male patient taking Hepsera (View Usage) (Dosage: ) . Location: JAPAN , 56 years of age, After Hepsera was administered, patient had the following side effects: tubulointerstitial nephritis. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6545928-1 | Haematemesis
on Jan 11, 2010 Female patient from KOREA, REPUBLIC OF , 61 years of age, weighting 144.6 lb, was diagnosed with hepatitis b (What is hepatitis b?), antiviral treatment, vitamin c, varices oesophageal and was treated with Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: haematemesis. Hepsera dosage: 10mg Per Day. During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ). Patient was hospitalized.

6542740-4 | Hepatic Neoplasm Malignant, Metastases To Abdominal Cavity, Omentectomy
on Jan 05, 2010 Male patient from KOREA, REPUBLIC OF , weighting 129.0 lb, was diagnosed with hepatitis b (What is hepatitis b?), antiviral treatment, hypertension, gastric ulcer, vitamin c, hypovitaminosis and was treated with Hepsera (View Usage). Patient had the following side effects: hepatic neoplasm malignant, metastases to abdominal cavity, omentectomy. Hepsera dosage: 10mg Per Day. During the same period patient was treated with ZEFFIX (View Zeffix Review and Zeffix Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ). Patient was hospitalized.

6542715-5 | Hepatic Neoplasm Malignant Recurrent
Patient was taking Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: hepatic neoplasm malignant recurrent on Jan 11, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 48 years of age, weighting 145.3 lb, was diagnosed with hepatitis b (What is hepatitis b?), prophylaxis and. Hepsera dosage: 10mg Per Day. During the same period patient was treated with VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), ACSORBIC ACID (View Acsorbic Acid Review and Acsorbic Acid Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), URSODEOXYCHOLIC ACID (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), MEPERIDINE HCL (View Meperidine Hcl Review and Meperidine Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6542420-5 | Jaundice
Adverse event was reported on Jan 12, 2010 by a Male patient taking Hepsera (View Usage) (Dosage: 10mg Per Day) was diagnosed with hepatitis b (What is hepatitis b?), antiviral treatment and. Location: KOREA, REPUBLIC OF , weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?). During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), GRANISETRON (View Granisetron Review and Granisetron Label ). Patient was hospitalized.

6540405-6 | Tubulointerstitial Nephritis
on Jan 05, 2010 Male patient from JAPAN , 56 years of age, was treated with Hepsera (View Usage). Patient had the following side effects: tubulointerstitial nephritis. Hepsera dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6509174-X | Abdominal Pain Upper, Alanine Aminotransferase Increased, Hepatic Cyst
on Dec 09, 2009 Male patient from HONG KONG , 38 years of age, was treated with Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, hepatic cyst. Hepsera dosage: .

6481886-6 | Renal Failure
Patient was taking Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure on Dec 01, 2009 from GERMANY Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with hepatitis b (What is hepatitis b?) and. Hepsera dosage: .

6478853-5 | Alanine Aminotransferase Increased
Adverse event was reported on Nov 25, 2009 by a Male patient taking Hepsera (View Usage) (Dosage: ) . Location: HONG KONG , 38 years of age, Patient had the following side effects: alanine aminotransferase increased.

6475338-7 | Hepatitis B Dna Increased
on Nov 23, 2009 Male patient from JAPAN , 49 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and was treated with Hepsera (View Usage). After Hepsera was administered, patient had the following side effects: hepatitis b dna increased. Hepsera dosage: 100mg Per Day. During the same period patient was treated with LAMIVUDINE (100mg Per Day) (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

6472466-7 | Fanconi Syndrome Acquired, Osteomalacia
on Nov 18, 2009 Female patient from UNITED KINGDOM , 57 years of age, weighting 321.9 lb, was diagnosed with hepatitis b (What is hepatitis b?), gastritis, hepatic cirrhosis, osteoporosis (What is osteoporosis?) and was treated with Hepsera (View Usage). Patient experienced the following unwanted or unexpected effects: fanconi syndrome acquired, osteomalacia. Hepsera dosage: . During the same period patient was treated with ZEFIX (View Zefix Review and Zefix Label ), GASTER (View Gaster Review and Gaster Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), PORTALAK (View Portalak Review and Portalak Label ), LIVACT (View Livact Review and Livact Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), ALFAROL (View Alfarol Review and Alfarol Label ). Patient was hospitalized.

6462782-7 | Glomerular Filtration Rate Decreased, Osteoporosis, Overdose, Pathological Fracture, Peripheral Arterial Occlusive Disease, Spinal Compression Fracture
Patient was taking Hepsera (View Usage). Patient had the following side effects: glomerular filtration rate decreased, osteoporosis (What is osteoporosis?), overdose, pathological fracture, peripheral arterial occlusive disease, spinal compression fracture on Nov 25, 2009 from AUSTRIA Additional patient health information: Male patient , weighting 147.7 lb, was diagnosed with hepatitis b (What is hepatitis b?), hiv infection (What is hiv infection?), prophylaxis against gastrointestinal ulcer, osteoporosis (What is osteoporosis?), antifungal prophylaxis and. Hepsera dosage: . During the same period patient was treated with LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), COTRIMOXAZOLE (View Cotrimoxazole Review and Cotrimoxazole Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), CAL D VITA (View Cal-d-vita Review and Cal-d-vita Label ). Patient was hospitalized and became disabled.